- Professor, Psychiatry & Human Behavior
- Outreach Director, TNT Fellowships
Research Interests
- Bipolar disorder
- Depression
- Schizophrenia
Publications
- Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart review. Ment Health Clin. 2023 Oct; 13(5):225-232. Meyer JM, Chepke C, Bera RB, Pérez-Rodríguez MM, Lundt L, Franey EG, Dhanda R, Benning B, Bron M, Yonan C. PMID: 38131059.
- Clinician Perceptions of the Negative Impact of Telehealth Services in the Management of Drug-Induced Movement Disorders and Opportunities for Quality Improvement: A 2021 Internet-Based Survey. Neuropsychiatr Dis Treat. 2022; 18:2945-2955. Bera R, Bron M, Benning B, Cicero S, Calara H, Darling D, Franey E, Martello K, Yonan C. PMID: 36570023.
- Nationwide Needs Assessment Survey of Financial Literacy Among Psychiatry Residents. Acad Psychiatry. 2022 06; 46(3):401-402. Wang A, Bera K, Sharma AN, Nguyen BN, Rojek NW, Bera R. PMID: 34145561.
- Suicide hotspots, interventions, and future areas of work at a Californian university. Death Stud. 2020; 44(9):569-577. Waalen A, Bera K, Bera R. PMID: 31008693.
- Modafinil associated with new-onset obsessivecompulsive disorder. Ann Clin Psychiatry. 2018 02; 30(1):70-71. Lochhead JD, Nelson MA, Bera R. PMID: 29373621.
- A Pilot Study of Cultural/Racial Differences in Patient Perspectives on Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia. Clin Schizophr Relat Psychoses. 2017 Winter; 10(4):211-221. Potkin SG, Bera R, Eramo A, Lau G. PMID: 24846880.
- Hospitalization resource utilization and costs among Medicaid insured patients with schizophrenia with different treatment durations of long-acting injectable antipsychotic therapy. J Clin Psychopharmacol. 2014 Feb; 34(1):30-5. Bera R, Offord S, Zubek D, Lau G, Lin J, Karson C. PMID: 24135840.
- Patient outcomes within schizophrenia treatment: a look at the role of long-acting injectable antipsychotics. J Clin Psychiatry. 2014; 75 Suppl 2:30-3. Bera RB. PMID: 24919169.
- Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia. BMC Psychiatry. 2013 Oct 16; 13:261. Potkin S, Bera R, Zubek D, Lau G. PMID: 24131801.
- Impact on healthcare resource usage and costs among Medicaid-insured schizophrenia patients after initiation of treatment with long-acting injectable antipsychotics. J Med Econ. 2013; 16(4):522-8. Bera R, Offord S, Zubek D, Lau G, Lin J, Baker RA, Karson C. PMID: 23360177.
- Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability. Clin Ther. 2002 Nov; 24(11):1809-23. Potkin SG, Thyrum PT, Bera R, Carreon D, Alva G, Kalali AH, Yeh C. PMID: 12501876.
- The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine. J Clin Psychopharmacol. 2002 Apr; 22(2):121-30. Potkin SG, Thyrum PT, Alva G, Bera R, Yeh C, Arvanitis LA. PMID: 11910256.
- Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. J Clin Psychiatry. 1994 Sep; 55 Suppl B:133-6. Potkin SG, Bera R, Gulasekaram B, Costa J, Hayes S, Jin Y, Richmond G, Carreon D, Sitanggan K, Gerber B. PMID: 7961557.
- Alterations in brain polyribosomal RNA translation and lymphocyte proliferation in prenatal ethanol-exposed rats. Alcohol Clin Exp Res. 1992 Jun; 16(3):436-42. Tewari S, Diano M, Bera R, Nguyen Q, Parekh H. PMID: 1626642.
- Control of bed-wetting with benztropine. Am J Psychiatry. 1990 May; 147(5):674. Costa JF, Sramek J, Bera RB, Brenneman M, Cristobal M. PMID: 2327502.